These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8703692)

  • 1. New 'calibrator' should improve prostate cancer testing.
    Oncology (Williston Park); 1995 Nov; 9(11):1222. PubMed ID: 8703692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
    Kuruma H; Egawa S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection.
    Kline EE; Treat EG; Averna TA; Davis MS; Smith AY; Sillerud LO
    J Urol; 2006 Nov; 176(5):2274-9. PubMed ID: 17070311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSA: prostate-specific antigen, persisting scientific ambiguities.
    Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
    [No Abstract]   [Full Text] [Related]  

  • 5. [PSA standardization; the past progress and some problems in the future].
    Kano S
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():238-49. PubMed ID: 22207979
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of laboratory testing methods for prostate-specific antigen.
    Robinson JA; Martin SM
    Clin Lab Sci; 1993 Dec; 6(6):342-5. PubMed ID: 10146635
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA; Cooke RR; Weinstein P; Nacey JN
    Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missing agreement between the two IMMULITE® PSA assays.
    Fischer K; Theil G; Hoda R; Fornara P
    Clin Chem Lab Med; 2013 Apr; 51(4):e37-9. PubMed ID: 23241597
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate-specific antigen as a tumor marker in prostate cancer.
    Kuriyama M
    Int J Urol; 1994 Jun; 1(2):99-113. PubMed ID: 7543013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of tandem PSA for the diagnosis and follow-up of prostate cancer].
    Okaneya T; Mizusawa H; Taguchi I; Yoneyama T
    Hinyokika Kiyo; 1996 Nov; 42(11):861-7. PubMed ID: 8973936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
    Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
    Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFSSAPS market survey of total PSA, free PSA and complexed PSA assay kits.
    Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)
    Prog Urol; 2007 Apr; 17(2):176-7. PubMed ID: 17489313
    [No Abstract]   [Full Text] [Related]  

  • 13. Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?
    Semjonow A; Oberpenning F; Weining C; Schön M; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP
    Clin Chem; 2001 Aug; 47(8):1472-5. PubMed ID: 11468242
    [No Abstract]   [Full Text] [Related]  

  • 14. PSA home tests: ban in France is welcome.
    Prescrire Int; 2013 Sep; 22(141):218. PubMed ID: 24171220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical analysis of false elevations in PSA results reported with the Abbott AxSYM assay.
    Sokoll LJ; Partin AW; Nelson JB; Chan DW
    Prostate; 1999 Jan; 38(1):79-80. PubMed ID: 9973113
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of free PSA in discordance across commercial PSA assays.
    Strobel S; Smith K; Wolfert R; Rittenbouse H
    Clin Chem; 1996 Apr; 42(4):645-7. PubMed ID: 8605688
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of Tandem-R PSA and Markit-M PA in the diagnosis of prostate cancer].
    Okegawa T; Kato M; Miyata A; Murata A; Miura I; Yoneda T; Nutahara K; Higashihara E
    Hinyokika Kiyo; 1999 Mar; 45(3):175-8. PubMed ID: 10331169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present status of serum total PSA assay and factors responsible for the inter-kit deviations].
    Kano S
    Nihon Rinsho; 2000 Jul; 58 Suppl():112-7. PubMed ID: 11022696
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gamma-seminoprotein (gamma-Sm)].
    Miyahara S
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():698-701. PubMed ID: 16149615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.